MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cells trained to hunt myeloma show promise in early trial
Disease control Recruiting nowThis early-phase study tests a new therapy using a patient's own immune cells (T cells) that are trained to recognize and attack proteins found on myeloma cells. The goal is to find a safe dose and see if it can control the disease. It includes people with active multiple myeloma…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 18, 2026 11:51 UTC
-
Diet and supplements tested to stop blood cancer before it starts
Prevention Recruiting nowThis study tests whether a plant-based diet or supplements (omega-3 and curcumin) can change gut bacteria in people with early blood conditions called MGUS and smoldering multiple myeloma. These conditions can sometimes turn into active multiple myeloma, a type of blood cancer. T…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 22, 2026 11:59 UTC
-
Fasting and mediterranean diet tested in blood cancer patients
Symptom relief Recruiting nowThis study looks at whether a diet that includes longer overnight fasting and follows a Mediterranean eating pattern is practical for people with multiple myeloma or its early forms (MGUS or smoldering myeloma). About 120 adults will try this approach to see if they can stick wit…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 15, 2026 18:56 UTC
-
New study asks: how do early blood disorders really affect daily life?
Knowledge-focused Recruiting nowThis study looks at the quality of life of people with two early blood conditions: MGUS and smoldering myeloma. Researchers will ask 400 participants to fill out short questionnaires about their symptoms and concerns. The goal is to learn what matters most to patients, not to tes…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:06 UTC
-
Hunting for clues: study seeks to predict myeloma before it starts
Knowledge-focused Recruiting nowThis observational study follows 200 people with early blood conditions (MGUS or smoldering myeloma) that sometimes turn into multiple myeloma. Researchers will track age, blood protein levels, bone marrow cells, genes, and bone health to find patterns that predict progression. N…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:10 UTC
-
New PET tracer could spot Hard-to-See cancers
Knowledge-focused Recruiting nowThis early-phase study is testing a new imaging agent called [68Ga]-pentixafor to see how well it shows up on PET/CT scans in people with certain blood cancers (like multiple myeloma and non-Hodgkin lymphoma) and rare immune cell tumors. About 30 participants will get the agent a…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:08 UTC
-
Firefighters' cancer risk under microscope: new study launches
Knowledge-focused Recruiting nowThis study looks at whether firefighters' exposure to dangerous chemicals on the job raises their risk of developing early signs of blood cancers. Researchers will follow 300 firefighters aged 40-49 from the Charlotte Fire Department who have at least 5 years of experience. The g…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:05 UTC
-
1,000 volunteers help scientists unlock the mystery of myeloma progression
Knowledge-focused Recruiting nowThis study is for 1,000 adults with early blood conditions called MGUS or smoldering multiple myeloma. Researchers want to find out why some people's conditions stay stable while others progress to active multiple myeloma. Participants will provide samples and have regular check-…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:57 UTC
-
Could sleep apnea affect bone marrow in blood cancer patients?
Knowledge-focused Recruiting nowThis study looks at how common sleep apnea is in people with MGUS or multiple myeloma, and whether sleep apnea changes gene activity in bone marrow. About 200 participants will donate bone marrow samples during their regular care. The goal is to understand links between sleep dis…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Michael Tomasson • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC
-
Family history of blood cancer? new study aims to catch myeloma early
Knowledge-focused Recruiting nowThis study is looking for 2,000 people who have a close family member with a blood cancer like multiple myeloma. The goal is to find early warning signs of the disease by collecting blood samples and health information over time. Participants will not receive any treatment, but t…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC
-
Ohio study aims to track and support rare blood cancer patients
Knowledge-focused Recruiting nowThis study is creating a database of up to 5,000 people in Ohio with plasma cell disorders like multiple myeloma and amyloidosis. Researchers will track treatments, outcomes, and quality of life, while also offering patients access to expert consultations and information about su…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC
-
Can a plant-based diet boost gut health in blood cancer precursors?
Knowledge-focused Recruiting nowThis study looks at how a short-term plant-based diet or supplements (omega-3, curcumin, or probiotics) change levels of butyrate—a healthy gut compound—in people with smoldering multiple myeloma or MGUS. About 200 participants will be randomly assigned to one of the diet or supp…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
New italian network aims to catch rare blood disease earlier
Knowledge-focused Recruiting nowThis study is creating a network of hospitals in Italy to find and treat AL amyloidosis earlier. Researchers will screen people with certain blood conditions (MGUS or smoldering myeloma) using special tests. The goal is to speed up diagnosis, connect patients to the right care, a…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:07 UTC